ROLE OF THE INTERLEUKIN-5 RECEPTOR SYSTEM IN HEMATOPOIESIS - MOLECULAR-BASIS FOR OVERLAPPING FUNCTION OF CYTOKINES

被引:10
作者
TOMINAGA, A [1 ]
TAKAKI, S [1 ]
HITOSHI, Y [1 ]
TAKATSU, K [1 ]
机构
[1] UNIV TOKYO,INST MED SCI,DEPT IMMUNOL,MINATO KU,TOKYO 108,JAPAN
关键词
D O I
10.1002/bies.950140806
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin 5 (IL-5) is a kind of peptide hormone released from T lymphocytes of mammals infected with microorganisms or parasites. It is an acidic glycoprotein with a molecular mass of 40 to 50 kDa that consists of a homodimer of polypeptides. It controls hematopoiesis so that it increases natural immunity. In the mouse, IL-5 acts on committed B cells to induce differentiation into Ig-producing cells and on common progenitors for CD5+ pre-B cells and CD5+ macrophages to support their survival. The antibodies secreted by CD5+ B cells seem to be responsible for the primary protection against the infection with microorganisms or parasites. It also supports the growth and/or differentiation of eosinophil precursor and mature eosinophils, which can be effective for the removal of parasites in combination with the antibodies against them. Murine IL-5 receptor (IL-5R) consists of two different polypeptide chains; alpha-chain and beta-chain. The IL-5R alpha-chain is 60 kDa protein that binds IL-5 with low affinity. The IL-5R beta-chain is a 130 kDa protein which does not bind IL-5 by itself but is necessary to form the high affinity IL-5R. The beta-chain was identified by using one of the anti-IL-5R mAb and anti-IL-3R mAb as the IL-3R homologue. This beta-chain is also used as the beta-chain of GM-CSF receptor. This fact suggests that there is a common signaling mechanism among these cytokines and efficient cooperation among them. At the same time, these findings may explain the overlapping role of these cytokines in the development of granulocytes.
引用
收藏
页码:527 / 533
页数:7
相关论文
共 50 条
[31]   MOLECULAR AND CELLULAR BIOLOGY OF EOSINOPHIL DIFFERENTIATION FACTOR (INTERLEUKIN-5) AND ITS EFFECTS ON HUMAN AND MOUSE B-CELLS [J].
SANDERSON, CJ ;
CAMPBELL, HD ;
YOUNG, IG .
IMMUNOLOGICAL REVIEWS, 1988, 102 :29-50
[32]  
SWAIN SL, 1985, J IMMUNOL, V134, P3934
[33]   STRUCTURAL COMPARISON OF MURINE T-CELL (B151K12)-DERIVED T-CELL-REPLACING FACTOR (IL-5) WITH RIL-5 - DIMER FORMATION IS ESSENTIAL FOR THE EXPRESSION OF BIOLOGICAL-ACTIVITY [J].
TAKAHASHI, T ;
YAMAGUCHI, N ;
MITA, S ;
YAMAGUCHI, Y ;
SUDA, T ;
TOMINAGA, A ;
KIKUCHI, Y ;
MIURA, Y ;
TAKATSU, K .
MOLECULAR IMMUNOLOGY, 1990, 27 (09) :911-920
[34]   MOLECULAR-CLONING AND EXPRESSION OF THE MURINE INTERLEUKIN-5 RECEPTOR [J].
TAKAKI, S ;
TOMINAGA, A ;
HITOSHI, Y ;
MITA, S ;
SONODA, E ;
YAMAGUCHI, N ;
TAKATSU, K .
EMBO JOURNAL, 1990, 9 (13) :4367-4374
[35]   IDENTIFICATION OF THE 2ND SUBUNIT OF THE MURINE INTERLEUKIN-5 RECEPTOR - INTERLEUKIN-3 RECEPTOR-LIKE PROTEIN, AIC2B IS A COMPONENT OF THE HIGH-AFFINITY INTERLEUKIN-5 RECEPTOR [J].
TAKAKI, S ;
MITA, S ;
KITAMURA, T ;
YONEHARA, S ;
YAMAGUCHI, N ;
TOMINAGA, A ;
MIYAJIMA, A ;
TAKATSU, K .
EMBO JOURNAL, 1991, 10 (10) :2833-2838
[36]   T-CELL-REPLACING FACTOR (TRF) INTERLEUKIN-5 (IL-5) - MOLECULAR AND FUNCTIONAL-PROPERTIES [J].
TAKATSU, K ;
TOMINAGA, A ;
HARADA, N ;
MITA, S ;
MATSUMOTO, M ;
TAKAHASHI, T ;
KIKUCHI, Y ;
YAMAGUCHI, N .
IMMUNOLOGICAL REVIEWS, 1988, 102 :107-135
[37]  
TAKATSU K, 1980, J IMMUNOL, V125, P2646
[38]  
TAKATSU K, 1992, IN PRESS ANN NY ACAD
[39]   A HUMAN HIGH-AFFINITY INTERLEUKIN-5 RECEPTOR (IL5R) IS COMPOSED OF AN IL5-SPECIFIC ALPHA-CHAIN AND A BETA-CHAIN SHARED WITH THE RECEPTOR FOR GM-CSF [J].
TAVERNIER, J ;
DEVOS, R ;
CORNELIS, S ;
TUYPENS, T ;
VANDERHEYDEN, J ;
FIERS, W ;
PLAETINCK, G .
CELL, 1991, 66 (06) :1175-1184
[40]  
TOMINAGA A, 1990, J IMMUNOL, V144, P1345